Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Feasibility and Safety of the ACURATE Prime™ XL Aortic Valve System in Patients Indicated for TAVI: ACURATE Prime XL Human Feasibility Study

NCT05224245 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT05224245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05224245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Feasibility and Safety of the ACURATE Prime™ XL Aortic Valve System in Patients Indicated for TAVI: ACURATE Prime XL Human Feasibility Study
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
March 3, 2022
Completion date
May 24, 2023
Enrollment
13 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis